An Open-Label, Two-Period, Sequential Drug Interaction Study To Evaluate The Effect Of Multiple Doses Of Desvenlafaxine Succinate Sustained Release (DVS SR) On The Pharmacokinetics Of Midazolam When Coadministered In Healthy Subjects.
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2011
At a glance
- Drugs Desvenlafaxine; Midazolam
- Indications Anxiety disorders; Depressive disorders
- Focus Pharmacokinetics
- Sponsors Wyeth
- 23 Aug 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2010 Planned initiation date changed from 1 Aug 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 08 Jun 2010 Planned end date changed from 1 Oct 2009 to 1 Aug 2010 as reported by ClinicalTrials.gov.